Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2000
06/07/2000EP1005356A1 Novel antibacterial agents
06/07/2000CN1255864A Combination of ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
06/07/2000CN1255493A Novel dihydro and tetrahydro chinoline compounds, its prepn. method and medicinal compsns.
06/07/2000CN1053189C Pyridazino qujinoline compounds
06/07/2000CN1053188C Quinolizinone type compounds
06/06/2000US6071940 Synergistic mixtures with tebuconazole
06/06/2000US6071931 AT1 -receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
06/06/2000US6071930 Method for treating tumors using 2-aryl-naphthyridin-4-ones
06/06/2000US6071925 Antidepressants, anticonvulsants or antianxiety agents, also for treatment of memory loss in alzheimer's disease
06/06/2000US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases
06/06/2000US6071900 Heterocyclic compounds and their use
06/06/2000US6071895 Polar-substituted hydrocarbons
06/02/2000WO2000031082A1 Pyrimidin-4-enamine as fungicide
06/02/2000WO2000031078A1 1-acylazetidine derivatives
06/02/2000WO2000031077A1 Semi-hydrochloride of 8-cyan-1- cyclopropyl -7-(1s,6s-2 ,8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro -4-oxo-3- quinoline carboxylic acid
06/02/2000WO2000031076A1 Crystal modification b of 8-cyano-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluoro-1,4- dihydro-4- oxo-3-quinoline carboxylic acid
06/02/2000WO2000031075A1 Crystal modification a of 8-cyano-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro- 4-oxo-3- quinoline carboxylic acid
06/02/2000WO2000031063A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
06/02/2000WO2000031051A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
06/02/2000WO2000031037A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000WO2000030642A1 Use of nicergoline for treating spasmodism
06/02/2000WO2000030639A1 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
06/02/2000WO2000018388A3 Antibiotic compositions for treatment of the eye, ear and nose
06/02/2000WO2000010999A3 New compounds
06/02/2000CA2352526A1 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
06/02/2000CA2352261A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
06/02/2000CA2351865A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000CA2351725A1 Substituted pyrazoles as p38 kinase inhibitors
06/02/2000CA2348557A1 Pyrimidin-4-enamine as fungicide
05/2000
05/31/2000EP1004582A2 Pyridazino quinoline compounds
05/31/2000EP1004581A2 Process for the preparation of thalidomide
05/31/2000EP1004580A2 Imides as inhibitors of TNF alpha
05/31/2000EP1004572A2 Amines as inhibitors of TNF alpha
05/31/2000EP1003902A1 Method for racemic biochemical resolution of cis- and trans- pyrrolopiperidine
05/31/2000EP1003745A1 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
05/31/2000EP1003744A1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS
05/31/2000EP1003743A1 3,3-disubstituted piperidines as modulators of chemokine receptor activity
05/31/2000EP1003735A1 Quinolizine carboxylic acid derivatives
05/31/2000EP1003726A1 Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests
05/31/2000EP1003721A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
05/31/2000EP1003541A1 Inhibitors of hiv reverse transcriptase
05/31/2000EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
05/31/2000EP1003514A1 Cyclic amine modulators of chemokine receptor activity
05/31/2000DE19854357A1 Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure Semi-hydrochloride of 8-cyano-1-cyclopropyl-7- (1S, 6S-2,8-diazabicyclo / 4.3.0 / nonan-8-yl) -6-fluoro-1,4-dihydro-4-oxo -3-quinolinecarboxylic acid
05/31/2000DE19854356A1 Kristallmodifikation A von A crystal modification of 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
05/31/2000DE19854355A1 Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure Crystal modification B of 8-cyano-1-cyclopropyl-7- (1S, 6S-2,8-diazabicyclo / 4.3.O / nonan-8-yl) -6-fluoro-1,4-dihydro-4-oxo- 3-quinolinecarboxylic acid
05/31/2000CN1255126A Heterocyclically substituted aromatic amino compounds with herbicidal effect
05/31/2000CN1255042A Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
05/31/2000CN1052984C New erythromycin derivative and its preparing process and application in medicine
05/30/2000US6069150 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents
05/30/2000US6069149 Antiallergens, antiinflammatory agents
05/30/2000US6068845 Inhibitory activity on the abnormal production of extracellular matrices in dermal fibroblasts activated with tranforming growth factor beta by administering the plant extract of a plant belonging to the genus sophora
05/30/2000US6068695 Process for the continuous preparation of quinacridones
05/30/2000CA2012226C Olefinic 1h-imidazo [4,5-c]quinolin-4-amines
05/30/2000CA1341007C Alkyl- and alkenylsulfonylureas which are substituted in the heterocycle, processes for their preparation, and their use as herbicides or plant growth regulators
05/25/2000WO2000029412A1 PENTAAZA-CYCLOPENTA[A]NAPHTHALENE DERIVATIVES AS LIGANDS FOR GABAA α5 RECEPTORS
05/25/2000WO2000029411A1 An improved process for the preparation of 7-azaindolyl-3-carboxylic acid
05/25/2000WO2000029406A2 Novel isoxazoline fibrinogen receptor antagonists
05/25/2000DE19854147A1 Control of cocaine addiction comprises administration of N-substituted azabicycloalkane derivative
05/25/2000DE19826469A1 Verfahren zur Herstellung von 2,4-Dimethylcarbolin und 2,4-Dimethylpyrimido[1,2-a]indol A process for the preparation of 2,4-and 2,4-Dimethylcarbolin Dimethylpyrimido [1,2-a] indole
05/25/2000CA2349488A1 Pentaaza-cyclopenta¬a|naphthalene derivatives as ligands for gabaa alpha5 receptors
05/25/2000CA2345210A1 Novel isoxazoline fibrinogen receptor antagonists
05/24/2000EP1001970A1 Dipeptide derivatives as growth hormone secretagogues
05/24/2000EP1001955A1 1,2,4-triazolo 4,3-b]pyrido 3,2-d]pyridazine derivatives and pharmaceutical compositions containing them
05/24/2000EP1001936A1 Bis -acridinecarboxamide having anti-tumor activity
05/24/2000EP1001782A1 5,6-HETEROARYL-DIPYRIDO 2,3-$i(b):3',2'-$i(f)]AZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION
05/24/2000CN1052724C Optical active 2,3-dihydro-imidazole and [1,2-C] quinazoline derivative, preparation method and use thereof
05/24/2000CN1052722C Dibenzooxapine or thiapine derivative, its preparing method and drug composition
05/23/2000US6066730 Boronic ester and acid compounds, synthesis and uses
05/23/2000US6066648 Integrin receptor antagonists
05/23/2000US6066647 Zwitterionic forms of trovafloxacin
05/23/2000US6066639 Antitumor agents
05/23/2000US6066638 Fungicidal pyrimidinones
05/23/2000US6066633 Prevent tissue degradation
05/23/2000US6066596 Herbicidal synergistic composition, and method of controlling weeds
05/23/2000CA2200959C 2,7-substituted octahydro-1h-pyrido[1,2-a]pyrazine derivatives
05/18/2000WO2000027850A2 Crf receptor antagonists and methods relating thereto
05/18/2000WO2000027846A2 Crf receptor antagonists and methods relating thereto
05/18/2000WO2000027845A1 Spiro-indolines as y5 receptor antagonists
05/18/2000WO2000027820A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
05/18/2000WO2000027790A1 Mutilin compounds
05/18/2000WO2000027398A1 Pharmaceutical moxifloxacin preparation
05/18/2000WO2000027389A1 Oxy-vanadium (iv) complexes having spermicidal activity
05/18/2000WO2000010998A3 Pyridone antibiotic with improved safety profile
05/18/2000WO2000008202A3 3-methylidenyl-2-indolinone modulators of protein kinase
05/18/2000WO2000007544A3 Vitronectin receptor antagonists
05/18/2000WO2000006575A3 Azabicyclic compounds
05/18/2000CA2350714A1 Spiro-indolines as y5 receptor antagonists
05/18/2000CA2350642A1 Crf receptor antagonists and methods relating thereto
05/18/2000CA2349904A1 Crf receptor antagonists and methods relating thereto
05/18/2000CA2346898A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
05/18/2000CA2318162A1 Oxy-vanadium (iv) complexes having spermicidal activity
05/17/2000EP1000946A2 Pesticidal and parasiticidal use of 2-(substituted thio)thiazolo-[4,5-b]pyridine compounds
05/17/2000EP1000945A1 PROCESS FOR PRODUCING $g(b)-LACTAM DERIVATIVES
05/17/2000EP1000085A1 Treatment of insulin resistance with growth hormone secretagogues
05/17/2000EP1000064A1 Compounds
05/17/2000EP1000060A1 Novel compounds
05/17/2000EP1000059A1 Tricyclic vasopressin agonists
05/17/2000EP1000055A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
05/17/2000EP1000031A1 Vitronectin receptor antagonist